By guest contributor Dr. Elizabeth Bowman, University of Melbourne
Anecdotal evidence suggests more people working in parts of the financial services industry are using “smart drugs” with the aim of boosting their cognitive performance. However, little is known about the extent of this use. To that end, the Brain, Mind and Markets Laboratory at the University of Melbourne is conducting the first-ever survey of the use of “smart drugs” in the Australian financial services industry. The confidential and...